J Drugs Dermatol:敏感肌?试试补骨脂素天然抗衰老保湿霜

2021-08-05 MedSci原创 MedSci原创 发表于上海

敏感肌患者局部使用视黄醇以达到抗衰老的目的较难,因为视黄醇具有刺激性。补骨脂素是一种来自补骨脂种子的单萜类物质,研究发现其具有类视黄醇功能。该研究在敏感皮肤的受试者中考察了一种基于自然界的含有白桦醇的

敏感肌患者局部使用视黄醇以达到抗衰老的目的较难,因为视黄醇具有刺激性。补骨脂素是一种来自补骨脂种子的单萜类物质,研究发现其具有类视黄醇功能。该研究在敏感皮肤的受试者中考察了一种基于自然界的含有白桦醇的洁面乳和保湿剂的耐受性、功效和屏障作用,研究结果已发表于J Drugs Dermatol。

研究纳入60名女性受试者,Fitzpatrick皮肤类型I-V,年龄40-65岁,皮肤敏感,轻度至中度光损伤,研究为期4周。构建了一个敏感肌小组:1/3湿疹/特异性皮炎,1/3酒渣鼻,1/3化妆品不耐受综合症。受试者每天两次使用基于自然的清洁剂和保湿剂,在基线、使用后5-10分钟和第4周进行经表皮失水(TEWL)、角质测量、耐受性评估和疗效评估。

 

结果显示,从调查者评估的视觉光滑度、触觉光滑度、透明度、光泽度、整体外观和整体抗衰老方面来看,皮肤护理产品的耐受性和疗效良好(P<0.001)。脸颊角质测量显示,皮肤水分含量增加16%(P<0.001)。

综上,该研究结果表明,这种基于补骨脂酚的天然抗衰老保湿霜对皮肤敏感的人具有良好的耐受性和有效性。

 

原始出处:

 

Zoe Diana Draelos, et al., Clinical Evaluation of a Nature-Based Bakuchiol Anti-Aging Moisturizer for Sensitive Skin. J Drugs Dermatol. 2020 Dec 1;19(12):1181-1183. doi: 10.36849/JDD.2020.5522.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2163943, encodeId=f513216394379, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Fri Oct 20 12:24:22 CST 2023, time=2023-10-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1862355, encodeId=17d918623554f, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6262, encryptionId=1f0e626267, topicName=Drug)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baf586, createdName=wangbingxhy, createdTime=Fri Dec 10 15:36:34 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784779, encodeId=33d01e8477950, content=<a href='/topic/show?id=e451626993' target=_blank style='color:#2F92EE;'>#drugs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6269, encryptionId=e451626993, topicName=drugs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sun Nov 28 01:36:34 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005480, encodeId=13d610054803a, content=敏感肌的**, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7ea5277039, createdName=14835566m80暂无昵称, createdTime=Thu Aug 05 22:39:56 CST 2021, time=2021-08-05, status=1, ipAttribution=)]
    2023-10-20 1dea4a7em68(暂无匿称) 来自福建省

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2163943, encodeId=f513216394379, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Fri Oct 20 12:24:22 CST 2023, time=2023-10-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1862355, encodeId=17d918623554f, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6262, encryptionId=1f0e626267, topicName=Drug)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baf586, createdName=wangbingxhy, createdTime=Fri Dec 10 15:36:34 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784779, encodeId=33d01e8477950, content=<a href='/topic/show?id=e451626993' target=_blank style='color:#2F92EE;'>#drugs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6269, encryptionId=e451626993, topicName=drugs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sun Nov 28 01:36:34 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005480, encodeId=13d610054803a, content=敏感肌的**, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7ea5277039, createdName=14835566m80暂无昵称, createdTime=Thu Aug 05 22:39:56 CST 2021, time=2021-08-05, status=1, ipAttribution=)]
    2021-12-10 wangbingxhy
  3. [GetPortalCommentsPageByObjectIdResponse(id=2163943, encodeId=f513216394379, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Fri Oct 20 12:24:22 CST 2023, time=2023-10-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1862355, encodeId=17d918623554f, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6262, encryptionId=1f0e626267, topicName=Drug)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baf586, createdName=wangbingxhy, createdTime=Fri Dec 10 15:36:34 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784779, encodeId=33d01e8477950, content=<a href='/topic/show?id=e451626993' target=_blank style='color:#2F92EE;'>#drugs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6269, encryptionId=e451626993, topicName=drugs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sun Nov 28 01:36:34 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005480, encodeId=13d610054803a, content=敏感肌的**, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7ea5277039, createdName=14835566m80暂无昵称, createdTime=Thu Aug 05 22:39:56 CST 2021, time=2021-08-05, status=1, ipAttribution=)]
    2021-11-28 tsing_hit
  4. [GetPortalCommentsPageByObjectIdResponse(id=2163943, encodeId=f513216394379, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Fri Oct 20 12:24:22 CST 2023, time=2023-10-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1862355, encodeId=17d918623554f, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6262, encryptionId=1f0e626267, topicName=Drug)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baf586, createdName=wangbingxhy, createdTime=Fri Dec 10 15:36:34 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784779, encodeId=33d01e8477950, content=<a href='/topic/show?id=e451626993' target=_blank style='color:#2F92EE;'>#drugs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6269, encryptionId=e451626993, topicName=drugs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sun Nov 28 01:36:34 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005480, encodeId=13d610054803a, content=敏感肌的**, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7ea5277039, createdName=14835566m80暂无昵称, createdTime=Thu Aug 05 22:39:56 CST 2021, time=2021-08-05, status=1, ipAttribution=)]
    2021-08-05 14835566m80暂无昵称

    敏感肌的**

    0

相关资讯

Am J Clin Nutr:血液中类胡萝卜素、视黄醇、生育酚对前列腺癌的影响

有研究表明血液中类胡萝卜素、视黄醇或生育酚会导致前列腺癌风险增加,但是此类研究样本均较少,不能提供精确的评估,尤其是与该疾病的分级分期相关联系。因此研究者对已存在的研究进行合并分析,评估以上几种物质与前列腺癌风险的关系,同时探究该联系是否会因为疾病的分期分级而发生变化,或者其他因素会对探究结果产生影响。该研究共纳入了15项研究共计 11,239名研究对象,包括 1654 名晚期,1741 名进展期

J Drugs Dermatol:新型视黄醇换肤术能改善各种皮肤类型的老化和痤疮

面部化学换肤受到光老化、痤疮、黄褐斑患者的追捧。一种先进的、医生强度的表层换肤剂,含有3%的视黄醇和其他紧致和丰盈成分,被开发出来,用于去除角质,改善细纹和皱纹的外观,使皮肤丰满紧致,同时促进肤色明亮

AGING:视黄醇水平和老年中国人认知能力下降的关系

最近,研究人员进行了一项探究,目的是在老年中国人的群体中,评估循环脂溶性维生素状态与认知之间的关系。